Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 6.4B | 7.4B | 6.9B | 7.1B |
Cost of revenue | 5.0B | 5.8B | 5.4B | 5.6B |
Gross profit | 1.5B | 1.5B | 1.5B | 1.5B |
Operating expense | ||||
Research & development | 146M | — | — | — |
Selling general and admin | 577M | 585M | 612M | 643M |
Other operating expenses | — | — | — | — |
Operating income | 752M | 945M | 930M | 847M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 51M | 55M | 55M | 47M |
Other income expense | -140M | -98M | 134M | 24M |
Pretax income | 561M | 792M | 1.0B | 824M |
Tax provision | 152M | -399M | 235M | 243M |
Net income | 409M | 1.2B | 774M | 581M |
Basic EPS | 0.4 | 1.2 | 0.8 | 0.6 |
Diluted EPS | 0.4 | 1.2 | 0.8 | 0.6 |
Basic average shares | 992M | 990M | 993M | 996M |
Diluted average shares | 999M | 999M | 999M | 1.0B |
EBITDA | 897M | 1.4B | 1.3B | 1.2B |
Net income from continuing op. | 409M | 1.2B | 773M | 581M |
Minority interests | -7M | -12M | -8M | -2M |
Preferred stock dividends | — | — | — | — |